1-Minute Consult

Sherif B. Mossad, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Sherif B. Mossad, MD, FACP, FIDSA, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mossads@ccf.org

Sherif B. Mossad, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Sherif B. Mossad, MD, FACP, FIDSA, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mossads@ccf.org

Sherif B. Mossad, MD
Department of Infectious Disease, The Cleveland Clinic

Address: Sherif B. Mossad, MD, FACP, FIDSA, Department of Infectious Disease, S32, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: mossads@ccf.org

Thomas R. Hunt III, MD
Head, Section of Hand Surgery, Department of Orthopaedic Surgery, The Cleveland Clinic

Address: Thomas R. Hunt III, MD, Section of Hand Surgery, Department of Orthopaedic Surgery, A40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Thomas R. Hunt III, MD
Head, Section of Hand Surgery, Department of Orthopaedic Surgery, The Cleveland Clinic

Address: Thomas R. Hunt III, MD, Section of Hand Surgery, Department of Orthopaedic Surgery, A40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Thomas R. Hunt III, MD
Head, Section of Hand Surgery, Department of Orthopaedic Surgery, The Cleveland Clinic

Address: Thomas R. Hunt III, MD, Section of Hand Surgery, Department of Orthopaedic Surgery, A40, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

This paper discusses treatments that are not approved by the US Food and Drug Administration for the use under discussion.

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: utian@menopause.org

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: utian@menopause.org

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Wulf H. Utian, MD, BCH, PhD
Department of Obstetrics and Gynecology, The Cleveland Clinic; Professor Emeritus, Case Western Reserve University; Executive Director, The North American Menopause Society

Address: Wulf H. Utian, MD, Executive Director, The North American Menopause Society, 5900 Landerbrook Drive, Cleveland, OH 44124; e-mail: utian@menopause.org

The author has indicated that he has received research support from the Amylin, 3M, Barr Laboratories, Berlex Laboratories, Bristol-Myers Squibb, Byk Gulden, Eli Lilly, Endeavor Pharmaceuticals, Forest Laboratories, Neurocrine Biosciences, Novartis, Novo Nordisk, Organon, Pharmacia, Procter & Gamble, Pfizer, Roche, Sepracor, Solvay Pharmaceuticals, Wyeth, and Yamanouchi USA corporations and serves as a consultant for the Eli Lilly, Endeavor, Pfizer, Berlex, and Warner corporations.

This paper discusses therapies that are not approved by the US Food and Drug Administration for the use under discussion.

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: soffere@ccf.org

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: soffere@ccf.org

Bo Shen, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Edy E. Soffer, MD
Department of Gastroenterology and Hepatology, The Cleveland Clinic

Address: Edy E. Soffer, MD, Department of Gastroenterology and Hepatology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: soffere@ccf.org

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: ghaffas@ccf.org

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: ghaffas@ccf.org

John C. Hostetter, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Sasan Ghaffari, MD
Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Sasan Ghaffari, MD, Department of Cardiovascular Medicine, F15, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: ghaffas@ccf.org

Camille Sabella, MD
Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children’s Hospital at The Cleveland Clinic

Address: Camille Sabella, MD, Division of Pediatrics, Desk A120, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sabellc@ccf.org

Camille Sabella, MD
Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children’s Hospital at The Cleveland Clinic

Address: Camille Sabella, MD, Division of Pediatrics, Desk A120, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sabellc@ccf.org

Camille Sabella, MD
Division of Pediatrics, Section of Pediatric Infectious Diseases, The Children’s Hospital at The Cleveland Clinic

Address: Camille Sabella, MD, Division of Pediatrics, Desk A120, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail sabellc@ccf.org

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jaffera@ccf.org

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jaffera@ccf.org

Daniel J. Brotman, MD
Section of Hospital and Preoperative Medicine, Department of General Internal Medicine, The Cleveland Clinic

Amir Jaffer, MD
Medical Director, Internal Medicine Preoperative Assessment Consultation and Treatment (IMPACT) Center, and the Anticoagulation Clinic, Department of General Internal Medicine, The Cleveland Clinic

Address: Amir Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail jaffera@ccf.org

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic

Richard Lang, MD
Head, Section of Preventive Medicine; Chairman, Department of General Internal Medicine, The Cleveland Clinic

Address: Anil Jain, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic

Richard Lang, MD
Head, Section of Preventive Medicine; Chairman, Department of General Internal Medicine, The Cleveland Clinic

Address: Anil Jain, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Anil Jain, MD
Department of General Internal Medicine, The Cleveland Clinic

Richard Lang, MD
Head, Section of Preventive Medicine; Chairman, Department of General Internal Medicine, The Cleveland Clinic

Address: Anil Jain, MD, Department of General Internal Medicine, A91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Thomas Pickering, MD, DPhil
Michael and Zena Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

Address: Thomas Pickering, MD, DPhil, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1030, New York, NY 10029-6574

The author has indicated that he serves as a consultant for Lifeclinic.com and is on the speakers’ bureau of the Boehringer Ingelheim corporation.

Thomas Pickering, MD, DPhil
Michael and Zena Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

Address: Thomas Pickering, MD, DPhil, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1030, New York, NY 10029-6574

The author has indicated that he serves as a consultant for Lifeclinic.com and is on the speakers’ bureau of the Boehringer Ingelheim corporation.

Thomas Pickering, MD, DPhil
Michael and Zena Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York

Address: Thomas Pickering, MD, DPhil, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, Box 1030, New York, NY 10029-6574

The author has indicated that he serves as a consultant for Lifeclinic.com and is on the speakers’ bureau of the Boehringer Ingelheim corporation.